nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—Discomfort—Betamethasone—rheumatoid arthritis	0.000178	0.000249	CcSEcCtD
Pramipexole—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000178	0.000249	CcSEcCtD
Pramipexole—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000177	0.000248	CcSEcCtD
Pramipexole—Pain—Prednisolone—rheumatoid arthritis	0.000177	0.000248	CcSEcCtD
Pramipexole—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000175	0.000246	CcSEcCtD
Pramipexole—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000175	0.000246	CcSEcCtD
Pramipexole—Nausea—Leflunomide—rheumatoid arthritis	0.000175	0.000245	CcSEcCtD
Pramipexole—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000174	0.000244	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000174	0.000244	CcSEcCtD
Pramipexole—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000174	0.000244	CcSEcCtD
Pramipexole—Vision blurred—Prednisone—rheumatoid arthritis	0.000173	0.000243	CcSEcCtD
Pramipexole—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000173	0.000243	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000173	0.000243	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000173	0.000242	CcSEcCtD
Pramipexole—Pain—Hydrocortisone—rheumatoid arthritis	0.000173	0.000242	CcSEcCtD
Pramipexole—Oedema—Betamethasone—rheumatoid arthritis	0.000172	0.000242	CcSEcCtD
Pramipexole—Oedema—Dexamethasone—rheumatoid arthritis	0.000172	0.000242	CcSEcCtD
Pramipexole—Insomnia—Triamcinolone—rheumatoid arthritis	0.000172	0.000241	CcSEcCtD
Pramipexole—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000172	0.00024	CcSEcCtD
Pramipexole—Infection—Betamethasone—rheumatoid arthritis	0.000171	0.00024	CcSEcCtD
Pramipexole—Infection—Dexamethasone—rheumatoid arthritis	0.000171	0.00024	CcSEcCtD
Pramipexole—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000171	0.000239	CcSEcCtD
Pramipexole—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000171	0.000239	CcSEcCtD
Pramipexole—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.00017	0.000239	CcSEcCtD
Pramipexole—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.00017	0.000238	CcSEcCtD
Pramipexole—Visual impairment—Methotrexate—rheumatoid arthritis	0.00017	0.000238	CcSEcCtD
Pramipexole—Anaemia—Prednisone—rheumatoid arthritis	0.00017	0.000238	CcSEcCtD
Pramipexole—Shock—Betamethasone—rheumatoid arthritis	0.00017	0.000238	CcSEcCtD
Pramipexole—Shock—Dexamethasone—rheumatoid arthritis	0.00017	0.000238	CcSEcCtD
Pramipexole—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000169	0.000237	CcSEcCtD
Pramipexole—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000169	0.000237	CcSEcCtD
Pramipexole—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000169	0.000237	CcSEcCtD
Pramipexole—Agitation—Prednisone—rheumatoid arthritis	0.000169	0.000237	CcSEcCtD
Pramipexole—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000169	0.000236	CcSEcCtD
Pramipexole—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000169	0.000236	CcSEcCtD
Pramipexole—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000168	0.000236	CcSEcCtD
Pramipexole—Tachycardia—Betamethasone—rheumatoid arthritis	0.000168	0.000236	CcSEcCtD
Pramipexole—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000167	0.000234	CcSEcCtD
Pramipexole—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000167	0.000234	CcSEcCtD
Pramipexole—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000167	0.000234	CcSEcCtD
Pramipexole—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000167	0.000233	CcSEcCtD
Pramipexole—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000167	0.000233	CcSEcCtD
Pramipexole—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000166	0.000233	CcSEcCtD
Pramipexole—Malaise—Prednisone—rheumatoid arthritis	0.000166	0.000232	CcSEcCtD
Pramipexole—Vertigo—Prednisone—rheumatoid arthritis	0.000165	0.000232	CcSEcCtD
Pramipexole—Eye disorder—Methotrexate—rheumatoid arthritis	0.000165	0.000231	CcSEcCtD
Pramipexole—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000165	0.000231	CcSEcCtD
Pramipexole—Syncope—Prednisone—rheumatoid arthritis	0.000165	0.000231	CcSEcCtD
Pramipexole—Tinnitus—Methotrexate—rheumatoid arthritis	0.000165	0.000231	CcSEcCtD
Pramipexole—Anorexia—Betamethasone—rheumatoid arthritis	0.000164	0.00023	CcSEcCtD
Pramipexole—Anorexia—Dexamethasone—rheumatoid arthritis	0.000164	0.00023	CcSEcCtD
Pramipexole—Urticaria—Prednisolone—rheumatoid arthritis	0.000164	0.00023	CcSEcCtD
Pramipexole—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000164	0.00023	CcSEcCtD
Pramipexole—Fatigue—Triamcinolone—rheumatoid arthritis	0.000164	0.000229	CcSEcCtD
Pramipexole—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000164	0.000229	CcSEcCtD
Pramipexole—Asthenia—Cyclosporine—rheumatoid arthritis	0.000163	0.000228	CcSEcCtD
Pramipexole—Pain—Triamcinolone—rheumatoid arthritis	0.000163	0.000228	CcSEcCtD
Pramipexole—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000162	0.000227	CcSEcCtD
Pramipexole—Hypotension—Betamethasone—rheumatoid arthritis	0.000161	0.000226	CcSEcCtD
Pramipexole—Hypotension—Dexamethasone—rheumatoid arthritis	0.000161	0.000226	CcSEcCtD
Pramipexole—Pruritus—Cyclosporine—rheumatoid arthritis	0.000161	0.000225	CcSEcCtD
Pramipexole—Urticaria—Hydrocortisone—rheumatoid arthritis	0.00016	0.000225	CcSEcCtD
Pramipexole—Angiopathy—Methotrexate—rheumatoid arthritis	0.00016	0.000224	CcSEcCtD
Pramipexole—Immune system disorder—Methotrexate—rheumatoid arthritis	0.00016	0.000223	CcSEcCtD
Pramipexole—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.00016	0.000223	CcSEcCtD
Pramipexole—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.00016	0.000223	CcSEcCtD
Pramipexole—Convulsion—Prednisone—rheumatoid arthritis	0.000159	0.000223	CcSEcCtD
Pramipexole—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000159	0.000223	CcSEcCtD
Pramipexole—Hypertension—Prednisone—rheumatoid arthritis	0.000159	0.000223	CcSEcCtD
Pramipexole—Chills—Methotrexate—rheumatoid arthritis	0.000159	0.000222	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000157	0.00022	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000157	0.00022	CcSEcCtD
Pramipexole—Arthralgia—Prednisone—rheumatoid arthritis	0.000157	0.000219	CcSEcCtD
Pramipexole—Myalgia—Prednisone—rheumatoid arthritis	0.000157	0.000219	CcSEcCtD
Pramipexole—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000157	0.000219	CcSEcCtD
Pramipexole—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000156	0.000219	CcSEcCtD
Pramipexole—Anxiety—Prednisone—rheumatoid arthritis	0.000156	0.000219	CcSEcCtD
Pramipexole—Alopecia—Methotrexate—rheumatoid arthritis	0.000156	0.000219	CcSEcCtD
Pramipexole—Insomnia—Betamethasone—rheumatoid arthritis	0.000156	0.000218	CcSEcCtD
Pramipexole—Insomnia—Dexamethasone—rheumatoid arthritis	0.000156	0.000218	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000156	0.000218	CcSEcCtD
Pramipexole—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000155	0.000218	CcSEcCtD
Pramipexole—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000155	0.000217	CcSEcCtD
Pramipexole—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000155	0.000217	CcSEcCtD
Pramipexole—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000155	0.000217	CcSEcCtD
Pramipexole—Discomfort—Prednisone—rheumatoid arthritis	0.000155	0.000217	CcSEcCtD
Pramipexole—Mental disorder—Methotrexate—rheumatoid arthritis	0.000155	0.000217	CcSEcCtD
Pramipexole—Malnutrition—Methotrexate—rheumatoid arthritis	0.000154	0.000215	CcSEcCtD
Pramipexole—Erythema—Methotrexate—rheumatoid arthritis	0.000154	0.000215	CcSEcCtD
Pramipexole—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000152	0.000213	CcSEcCtD
Pramipexole—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000152	0.000213	CcSEcCtD
Pramipexole—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000152	0.000213	CcSEcCtD
Pramipexole—Urticaria—Triamcinolone—rheumatoid arthritis	0.000151	0.000211	CcSEcCtD
Pramipexole—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000151	0.000211	CcSEcCtD
Pramipexole—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000151	0.000211	CcSEcCtD
Pramipexole—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.00015	0.00021	CcSEcCtD
Pramipexole—Dizziness—Cyclosporine—rheumatoid arthritis	0.00015	0.00021	CcSEcCtD
Pramipexole—Oedema—Prednisone—rheumatoid arthritis	0.00015	0.00021	CcSEcCtD
Pramipexole—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.00015	0.00021	CcSEcCtD
Pramipexole—Decreased appetite—Betamethasone—rheumatoid arthritis	0.00015	0.00021	CcSEcCtD
Pramipexole—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.00015	0.00021	CcSEcCtD
Pramipexole—Infection—Prednisone—rheumatoid arthritis	0.000149	0.000209	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000149	0.000209	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000149	0.000209	CcSEcCtD
Pramipexole—Back pain—Methotrexate—rheumatoid arthritis	0.000149	0.000208	CcSEcCtD
Pramipexole—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000149	0.000208	CcSEcCtD
Pramipexole—Fatigue—Betamethasone—rheumatoid arthritis	0.000149	0.000208	CcSEcCtD
Pramipexole—Fatigue—Dexamethasone—rheumatoid arthritis	0.000149	0.000208	CcSEcCtD
Pramipexole—Shock—Prednisone—rheumatoid arthritis	0.000148	0.000207	CcSEcCtD
Pramipexole—Pain—Dexamethasone—rheumatoid arthritis	0.000147	0.000207	CcSEcCtD
Pramipexole—Pain—Betamethasone—rheumatoid arthritis	0.000147	0.000207	CcSEcCtD
Pramipexole—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000147	0.000206	CcSEcCtD
Pramipexole—Tachycardia—Prednisone—rheumatoid arthritis	0.000147	0.000205	CcSEcCtD
Pramipexole—Skin disorder—Prednisone—rheumatoid arthritis	0.000146	0.000204	CcSEcCtD
Pramipexole—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000145	0.000203	CcSEcCtD
Pramipexole—Vision blurred—Methotrexate—rheumatoid arthritis	0.000145	0.000203	CcSEcCtD
Pramipexole—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000145	0.000203	CcSEcCtD
Pramipexole—Vomiting—Cyclosporine—rheumatoid arthritis	0.000144	0.000202	CcSEcCtD
Pramipexole—Rash—Cyclosporine—rheumatoid arthritis	0.000143	0.000201	CcSEcCtD
Pramipexole—Anorexia—Prednisone—rheumatoid arthritis	0.000143	0.0002	CcSEcCtD
Pramipexole—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000143	0.0002	CcSEcCtD
Pramipexole—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000143	0.0002	CcSEcCtD
Pramipexole—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000143	0.0002	CcSEcCtD
Pramipexole—Headache—Cyclosporine—rheumatoid arthritis	0.000142	0.000199	CcSEcCtD
Pramipexole—Anaemia—Methotrexate—rheumatoid arthritis	0.000142	0.000199	CcSEcCtD
Pramipexole—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000142	0.000199	CcSEcCtD
Pramipexole—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000142	0.000199	CcSEcCtD
Pramipexole—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000141	0.000198	CcSEcCtD
Pramipexole—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000141	0.000198	CcSEcCtD
Pramipexole—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.00014	0.000196	CcSEcCtD
Pramipexole—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.00014	0.000196	CcSEcCtD
Pramipexole—Malaise—Methotrexate—rheumatoid arthritis	0.000139	0.000194	CcSEcCtD
Pramipexole—Vertigo—Methotrexate—rheumatoid arthritis	0.000138	0.000194	CcSEcCtD
Pramipexole—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000138	0.000193	CcSEcCtD
Pramipexole—Leukopenia—Methotrexate—rheumatoid arthritis	0.000138	0.000193	CcSEcCtD
Pramipexole—Urticaria—Dexamethasone—rheumatoid arthritis	0.000137	0.000192	CcSEcCtD
Pramipexole—Urticaria—Betamethasone—rheumatoid arthritis	0.000137	0.000192	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000137	0.000192	CcSEcCtD
Pramipexole—Dizziness—Prednisolone—rheumatoid arthritis	0.000137	0.000191	CcSEcCtD
Pramipexole—Asthenia—Triamcinolone—rheumatoid arthritis	0.000136	0.000191	CcSEcCtD
Pramipexole—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000136	0.000191	CcSEcCtD
Pramipexole—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000136	0.000191	CcSEcCtD
Pramipexole—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000136	0.000191	CcSEcCtD
Pramipexole—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000136	0.000191	CcSEcCtD
Pramipexole—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000136	0.000191	CcSEcCtD
Pramipexole—Insomnia—Prednisone—rheumatoid arthritis	0.000136	0.00019	CcSEcCtD
Pramipexole—Nausea—Cyclosporine—rheumatoid arthritis	0.000135	0.000189	CcSEcCtD
Pramipexole—Paraesthesia—Prednisone—rheumatoid arthritis	0.000135	0.000189	CcSEcCtD
Pramipexole—Pruritus—Triamcinolone—rheumatoid arthritis	0.000134	0.000188	CcSEcCtD
Pramipexole—Cough—Methotrexate—rheumatoid arthritis	0.000134	0.000188	CcSEcCtD
Pramipexole—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000134	0.000188	CcSEcCtD
Pramipexole—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000133	0.000187	CcSEcCtD
Pramipexole—Convulsion—Methotrexate—rheumatoid arthritis	0.000133	0.000187	CcSEcCtD
Pramipexole—Dyspepsia—Prednisone—rheumatoid arthritis	0.000132	0.000185	CcSEcCtD
Pramipexole—Arthralgia—Methotrexate—rheumatoid arthritis	0.000131	0.000183	CcSEcCtD
Pramipexole—Chest pain—Methotrexate—rheumatoid arthritis	0.000131	0.000183	CcSEcCtD
Pramipexole—Myalgia—Methotrexate—rheumatoid arthritis	0.000131	0.000183	CcSEcCtD
Pramipexole—Decreased appetite—Prednisone—rheumatoid arthritis	0.000131	0.000183	CcSEcCtD
Pramipexole—Rash—Prednisolone—rheumatoid arthritis	0.00013	0.000183	CcSEcCtD
Pramipexole—Dermatitis—Prednisolone—rheumatoid arthritis	0.00013	0.000182	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.00013	0.000182	CcSEcCtD
Pramipexole—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.00013	0.000182	CcSEcCtD
Pramipexole—Fatigue—Prednisone—rheumatoid arthritis	0.000129	0.000181	CcSEcCtD
Pramipexole—Headache—Prednisolone—rheumatoid arthritis	0.000129	0.000181	CcSEcCtD
Pramipexole—Discomfort—Methotrexate—rheumatoid arthritis	0.000129	0.000181	CcSEcCtD
Pramipexole—Constipation—Prednisone—rheumatoid arthritis	0.000128	0.00018	CcSEcCtD
Pramipexole—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000128	0.00018	CcSEcCtD
Pramipexole—Rash—Hydrocortisone—rheumatoid arthritis	0.000127	0.000178	CcSEcCtD
Pramipexole—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000127	0.000178	CcSEcCtD
Pramipexole—Confusional state—Methotrexate—rheumatoid arthritis	0.000127	0.000177	CcSEcCtD
Pramipexole—Headache—Hydrocortisone—rheumatoid arthritis	0.000126	0.000177	CcSEcCtD
Pramipexole—Dizziness—Triamcinolone—rheumatoid arthritis	0.000126	0.000176	CcSEcCtD
Pramipexole—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000125	0.000176	CcSEcCtD
Pramipexole—Infection—Methotrexate—rheumatoid arthritis	0.000125	0.000175	CcSEcCtD
Pramipexole—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000124	0.000173	CcSEcCtD
Pramipexole—Asthenia—Betamethasone—rheumatoid arthritis	0.000124	0.000173	CcSEcCtD
Pramipexole—Asthenia—Dexamethasone—rheumatoid arthritis	0.000124	0.000173	CcSEcCtD
Pramipexole—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000123	0.000172	CcSEcCtD
Pramipexole—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000123	0.000172	CcSEcCtD
Pramipexole—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000123	0.000172	CcSEcCtD
Pramipexole—Nausea—Prednisolone—rheumatoid arthritis	0.000123	0.000172	CcSEcCtD
Pramipexole—Pruritus—Betamethasone—rheumatoid arthritis	0.000122	0.000171	CcSEcCtD
Pramipexole—Pruritus—Dexamethasone—rheumatoid arthritis	0.000122	0.000171	CcSEcCtD
Pramipexole—Skin disorder—Methotrexate—rheumatoid arthritis	0.000122	0.000171	CcSEcCtD
Pramipexole—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.000121	0.00017	CcSEcCtD
Pramipexole—Vomiting—Triamcinolone—rheumatoid arthritis	0.000121	0.000169	CcSEcCtD
Pramipexole—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000121	0.000169	CcSEcCtD
Pramipexole—Nausea—Hydrocortisone—rheumatoid arthritis	0.00012	0.000168	CcSEcCtD
Pramipexole—Rash—Triamcinolone—rheumatoid arthritis	0.00012	0.000168	CcSEcCtD
Pramipexole—Dermatitis—Triamcinolone—rheumatoid arthritis	0.00012	0.000168	CcSEcCtD
Pramipexole—Anorexia—Methotrexate—rheumatoid arthritis	0.00012	0.000168	CcSEcCtD
Pramipexole—Rash—Methylprednisolone—rheumatoid arthritis	0.00012	0.000167	CcSEcCtD
Pramipexole—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000119	0.000167	CcSEcCtD
Pramipexole—Urticaria—Prednisone—rheumatoid arthritis	0.000119	0.000167	CcSEcCtD
Pramipexole—Headache—Triamcinolone—rheumatoid arthritis	0.000119	0.000167	CcSEcCtD
Pramipexole—Headache—Methylprednisolone—rheumatoid arthritis	0.000119	0.000166	CcSEcCtD
Pramipexole—Abdominal pain—Prednisone—rheumatoid arthritis	0.000119	0.000166	CcSEcCtD
Pramipexole—Body temperature increased—Prednisone—rheumatoid arthritis	0.000119	0.000166	CcSEcCtD
Pramipexole—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000118	0.000165	CcSEcCtD
Pramipexole—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000118	0.000165	CcSEcCtD
Pramipexole—Hypotension—Methotrexate—rheumatoid arthritis	0.000117	0.000164	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.000114	0.00016	CcSEcCtD
Pramipexole—Dizziness—Betamethasone—rheumatoid arthritis	0.000114	0.00016	CcSEcCtD
Pramipexole—Dizziness—Dexamethasone—rheumatoid arthritis	0.000114	0.00016	CcSEcCtD
Pramipexole—Insomnia—Methotrexate—rheumatoid arthritis	0.000114	0.000159	CcSEcCtD
Pramipexole—Nausea—Triamcinolone—rheumatoid arthritis	0.000113	0.000158	CcSEcCtD
Pramipexole—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000113	0.000158	CcSEcCtD
Pramipexole—Nausea—Methylprednisolone—rheumatoid arthritis	0.000113	0.000158	CcSEcCtD
Pramipexole—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000112	0.000157	CcSEcCtD
Pramipexole—Somnolence—Methotrexate—rheumatoid arthritis	0.000112	0.000156	CcSEcCtD
Pramipexole—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000111	0.000155	CcSEcCtD
Pramipexole—Dyspepsia—Methotrexate—rheumatoid arthritis	0.00011	0.000155	CcSEcCtD
Pramipexole—Vomiting—Dexamethasone—rheumatoid arthritis	0.00011	0.000154	CcSEcCtD
Pramipexole—Vomiting—Betamethasone—rheumatoid arthritis	0.00011	0.000154	CcSEcCtD
Pramipexole—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000109	0.000153	CcSEcCtD
Pramipexole—Rash—Betamethasone—rheumatoid arthritis	0.000109	0.000152	CcSEcCtD
Pramipexole—Rash—Dexamethasone—rheumatoid arthritis	0.000109	0.000152	CcSEcCtD
Pramipexole—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000109	0.000152	CcSEcCtD
Pramipexole—Dermatitis—Betamethasone—rheumatoid arthritis	0.000109	0.000152	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000108	0.000152	CcSEcCtD
Pramipexole—Fatigue—Methotrexate—rheumatoid arthritis	0.000108	0.000152	CcSEcCtD
Pramipexole—Headache—Betamethasone—rheumatoid arthritis	0.000108	0.000151	CcSEcCtD
Pramipexole—Headache—Dexamethasone—rheumatoid arthritis	0.000108	0.000151	CcSEcCtD
Pramipexole—Asthenia—Prednisone—rheumatoid arthritis	0.000108	0.000151	CcSEcCtD
Pramipexole—Pain—Methotrexate—rheumatoid arthritis	0.000107	0.00015	CcSEcCtD
Pramipexole—Pruritus—Prednisone—rheumatoid arthritis	0.000106	0.000149	CcSEcCtD
Pramipexole—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000103	0.000145	CcSEcCtD
Pramipexole—Diarrhoea—Prednisone—rheumatoid arthritis	0.000103	0.000144	CcSEcCtD
Pramipexole—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000103	0.000144	CcSEcCtD
Pramipexole—Nausea—Betamethasone—rheumatoid arthritis	0.000102	0.000143	CcSEcCtD
Pramipexole—Nausea—Dexamethasone—rheumatoid arthritis	0.000102	0.000143	CcSEcCtD
Pramipexole—Urticaria—Methotrexate—rheumatoid arthritis	9.97e-05	0.00014	CcSEcCtD
Pramipexole—Dizziness—Prednisone—rheumatoid arthritis	9.93e-05	0.000139	CcSEcCtD
Pramipexole—Abdominal pain—Methotrexate—rheumatoid arthritis	9.92e-05	0.000139	CcSEcCtD
Pramipexole—Body temperature increased—Methotrexate—rheumatoid arthritis	9.92e-05	0.000139	CcSEcCtD
Pramipexole—Vomiting—Prednisone—rheumatoid arthritis	9.55e-05	0.000134	CcSEcCtD
Pramipexole—Rash—Prednisone—rheumatoid arthritis	9.47e-05	0.000133	CcSEcCtD
Pramipexole—Dermatitis—Prednisone—rheumatoid arthritis	9.46e-05	0.000132	CcSEcCtD
Pramipexole—Headache—Prednisone—rheumatoid arthritis	9.41e-05	0.000132	CcSEcCtD
Pramipexole—Hypersensitivity—Methotrexate—rheumatoid arthritis	9.25e-05	0.00013	CcSEcCtD
Pramipexole—Asthenia—Methotrexate—rheumatoid arthritis	9.01e-05	0.000126	CcSEcCtD
Pramipexole—Nausea—Prednisone—rheumatoid arthritis	8.92e-05	0.000125	CcSEcCtD
Pramipexole—Pruritus—Methotrexate—rheumatoid arthritis	8.88e-05	0.000124	CcSEcCtD
Pramipexole—Diarrhoea—Methotrexate—rheumatoid arthritis	8.59e-05	0.00012	CcSEcCtD
Pramipexole—Dizziness—Methotrexate—rheumatoid arthritis	8.3e-05	0.000116	CcSEcCtD
Pramipexole—Vomiting—Methotrexate—rheumatoid arthritis	7.98e-05	0.000112	CcSEcCtD
Pramipexole—Rash—Methotrexate—rheumatoid arthritis	7.91e-05	0.000111	CcSEcCtD
Pramipexole—Dermatitis—Methotrexate—rheumatoid arthritis	7.91e-05	0.000111	CcSEcCtD
Pramipexole—Headache—Methotrexate—rheumatoid arthritis	7.86e-05	0.00011	CcSEcCtD
Pramipexole—Nausea—Methotrexate—rheumatoid arthritis	7.46e-05	0.000104	CcSEcCtD
Pramipexole—HTR1A—Signaling Pathways—LEP—rheumatoid arthritis	2.02e-05	7.08e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—POMC—rheumatoid arthritis	2.02e-05	7.07e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—LEP—rheumatoid arthritis	2.01e-05	7.04e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—POMC—rheumatoid arthritis	2.01e-05	7.04e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SPP1—rheumatoid arthritis	2.01e-05	7.02e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—CXCL8—rheumatoid arthritis	2e-05	6.99e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TYK2—rheumatoid arthritis	2e-05	6.98e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—POMC—rheumatoid arthritis	1.99e-05	6.98e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NOS3—rheumatoid arthritis	1.99e-05	6.96e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PTK2—rheumatoid arthritis	1.98e-05	6.92e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CCL2—rheumatoid arthritis	1.98e-05	6.92e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—FN1—rheumatoid arthritis	1.98e-05	6.91e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SPP1—rheumatoid arthritis	1.98e-05	6.91e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6R—rheumatoid arthritis	1.97e-05	6.9e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.97e-05	6.89e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6ST—rheumatoid arthritis	1.97e-05	6.89e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.97e-05	6.88e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NOS3—rheumatoid arthritis	1.96e-05	6.85e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—LEP—rheumatoid arthritis	1.96e-05	6.85e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCR5—rheumatoid arthritis	1.95e-05	6.83e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CCL2—rheumatoid arthritis	1.95e-05	6.83e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6R—rheumatoid arthritis	1.95e-05	6.81e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCL5—rheumatoid arthritis	1.94e-05	6.79e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—POMC—rheumatoid arthritis	1.93e-05	6.74e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL2RA—rheumatoid arthritis	1.92e-05	6.73e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCR5—rheumatoid arthritis	1.92e-05	6.72e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TP53—rheumatoid arthritis	1.91e-05	6.69e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—VEGFA—rheumatoid arthritis	1.91e-05	6.69e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CSF2—rheumatoid arthritis	1.91e-05	6.68e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL2—rheumatoid arthritis	1.91e-05	6.68e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—C3—rheumatoid arthritis	1.91e-05	6.67e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—FN1—rheumatoid arthritis	1.91e-05	6.67e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TYK2—rheumatoid arthritis	1.9e-05	6.66e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.9e-05	6.65e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—FN1—rheumatoid arthritis	1.9e-05	6.64e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CD80—rheumatoid arthritis	1.9e-05	6.63e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL2RA—rheumatoid arthritis	1.89e-05	6.62e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6ST—rheumatoid arthritis	1.89e-05	6.61e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ALB—rheumatoid arthritis	1.89e-05	6.59e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—IL2—rheumatoid arthritis	1.88e-05	6.59e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL2—rheumatoid arthritis	1.88e-05	6.57e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—C3—rheumatoid arthritis	1.88e-05	6.57e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NOS3—rheumatoid arthritis	1.87e-05	6.54e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—FN1—rheumatoid arthritis	1.85e-05	6.46e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6ST—rheumatoid arthritis	1.84e-05	6.43e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ALB—rheumatoid arthritis	1.83e-05	6.41e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CD80—rheumatoid arthritis	1.83e-05	6.4e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CD80—rheumatoid arthritis	1.82e-05	6.37e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—NOS3—rheumatoid arthritis	1.8e-05	6.31e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CXCL8—rheumatoid arthritis	1.8e-05	6.31e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—POMC—rheumatoid arthritis	1.8e-05	6.3e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SPP1—rheumatoid arthritis	1.8e-05	6.29e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TYK2—rheumatoid arthritis	1.8e-05	6.28e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.79e-05	6.26e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—LEP—rheumatoid arthritis	1.78e-05	6.21e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TYK2—rheumatoid arthritis	1.77e-05	6.2e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CD80—rheumatoid arthritis	1.77e-05	6.19e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CXCL8—rheumatoid arthritis	1.77e-05	6.17e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NOS3—rheumatoid arthritis	1.76e-05	6.17e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CCL2—rheumatoid arthritis	1.76e-05	6.16e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ALB—rheumatoid arthritis	1.76e-05	6.15e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6R—rheumatoid arthritis	1.76e-05	6.14e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TGFB1—rheumatoid arthritis	1.75e-05	6.14e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—NOS3—rheumatoid arthritis	1.75e-05	6.14e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—LEP—rheumatoid arthritis	1.75e-05	6.11e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCR5—rheumatoid arthritis	1.75e-05	6.11e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NOS3—rheumatoid arthritis	1.74e-05	6.08e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—POMC—rheumatoid arthritis	1.74e-05	6.08e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CXCL8—rheumatoid arthritis	1.74e-05	6.08e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—POMC—rheumatoid arthritis	1.73e-05	6.05e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL2—rheumatoid arthritis	1.72e-05	6.03e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL2RA—rheumatoid arthritis	1.72e-05	6.03e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—IL6—rheumatoid arthritis	1.71e-05	6e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL2—rheumatoid arthritis	1.71e-05	5.98e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—C3—rheumatoid arthritis	1.71e-05	5.97e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CCL2—rheumatoid arthritis	1.7e-05	5.95e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6R—rheumatoid arthritis	1.7e-05	5.93e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CCL2—rheumatoid arthritis	1.69e-05	5.92e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6R—rheumatoid arthritis	1.69e-05	5.9e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL2—rheumatoid arthritis	1.69e-05	5.9e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—POMC—rheumatoid arthritis	1.68e-05	5.88e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—NOS3—rheumatoid arthritis	1.68e-05	5.88e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—IL6—rheumatoid arthritis	1.68e-05	5.87e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—FN1—rheumatoid arthritis	1.68e-05	5.86e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6ST—rheumatoid arthritis	1.67e-05	5.84e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL2—rheumatoid arthritis	1.66e-05	5.81e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CXCL8—rheumatoid arthritis	1.66e-05	5.8e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—IL6—rheumatoid arthritis	1.65e-05	5.78e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PTGS2—rheumatoid arthritis	1.65e-05	5.77e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—FN1—rheumatoid arthritis	1.65e-05	5.77e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CCL2—rheumatoid arthritis	1.65e-05	5.76e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.64e-05	5.74e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6R—rheumatoid arthritis	1.64e-05	5.74e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—POMC—rheumatoid arthritis	1.63e-05	5.71e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MMP9—rheumatoid arthritis	1.63e-05	5.7e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NFKB1—rheumatoid arthritis	1.61e-05	5.64e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CD80—rheumatoid arthritis	1.61e-05	5.62e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PTGS2—rheumatoid arthritis	1.6e-05	5.61e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TYK2—rheumatoid arthritis	1.6e-05	5.6e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MMP9—rheumatoid arthritis	1.6e-05	5.58e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—LEP—rheumatoid arthritis	1.59e-05	5.56e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MAPK8—rheumatoid arthritis	1.59e-05	5.55e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL2—rheumatoid arthritis	1.58e-05	5.54e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CD80—rheumatoid arthritis	1.58e-05	5.53e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NFKB1—rheumatoid arthritis	1.58e-05	5.52e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL6—rheumatoid arthritis	1.58e-05	5.51e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MMP9—rheumatoid arthritis	1.57e-05	5.5e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NOS3—rheumatoid arthritis	1.57e-05	5.49e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.56e-05	5.47e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NFKB1—rheumatoid arthritis	1.55e-05	5.44e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MAPK8—rheumatoid arthritis	1.55e-05	5.43e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TYK2—rheumatoid arthritis	1.54e-05	5.4e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CXCL8—rheumatoid arthritis	1.54e-05	5.4e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PTGS2—rheumatoid arthritis	1.54e-05	5.38e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TYK2—rheumatoid arthritis	1.54e-05	5.37e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MAPK8—rheumatoid arthritis	1.53e-05	5.34e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—POMC—rheumatoid arthritis	1.53e-05	5.34e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NOS3—rheumatoid arthritis	1.52e-05	5.3e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NOS3—rheumatoid arthritis	1.51e-05	5.27e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—POMC—rheumatoid arthritis	1.5e-05	5.25e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MMP9—rheumatoid arthritis	1.5e-05	5.25e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—FN1—rheumatoid arthritis	1.5e-05	5.25e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TYK2—rheumatoid arthritis	1.49e-05	5.23e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL2—rheumatoid arthritis	1.49e-05	5.23e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.49e-05	5.22e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCL2—rheumatoid arthritis	1.49e-05	5.22e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ALB—rheumatoid arthritis	1.49e-05	5.21e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6R—rheumatoid arthritis	1.49e-05	5.21e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL6—rheumatoid arthritis	1.49e-05	5.2e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NFKB1—rheumatoid arthritis	1.48e-05	5.19e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL2—rheumatoid arthritis	1.47e-05	5.16e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCL2—rheumatoid arthritis	1.47e-05	5.14e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL6—rheumatoid arthritis	1.47e-05	5.13e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NOS3—rheumatoid arthritis	1.47e-05	5.13e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6R—rheumatoid arthritis	1.46e-05	5.12e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—VEGFA—rheumatoid arthritis	1.46e-05	5.12e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MAPK8—rheumatoid arthritis	1.46e-05	5.1e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TP53—rheumatoid arthritis	1.44e-05	5.05e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CD80—rheumatoid arthritis	1.44e-05	5.03e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—VEGFA—rheumatoid arthritis	1.43e-05	5.01e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—NOS3—rheumatoid arthritis	1.42e-05	4.98e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MMP9—rheumatoid arthritis	1.41e-05	4.95e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—VEGFA—rheumatoid arthritis	1.41e-05	4.93e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.4e-05	4.89e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MMP9—rheumatoid arthritis	1.4e-05	4.88e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CXCL8—rheumatoid arthritis	1.39e-05	4.87e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NFKB1—rheumatoid arthritis	1.38e-05	4.83e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.38e-05	4.81e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—POMC—rheumatoid arthritis	1.37e-05	4.78e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MAPK8—rheumatoid arthritis	1.36e-05	4.75e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TYK2—rheumatoid arthritis	1.36e-05	4.74e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—VEGFA—rheumatoid arthritis	1.35e-05	4.71e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.34e-05	4.7e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TGFB1—rheumatoid arthritis	1.34e-05	4.7e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CXCL8—rheumatoid arthritis	1.34e-05	4.68e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCL2—rheumatoid arthritis	1.34e-05	4.68e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TYK2—rheumatoid arthritis	1.33e-05	4.67e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6R—rheumatoid arthritis	1.33e-05	4.66e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL2—rheumatoid arthritis	1.33e-05	4.66e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NOS3—rheumatoid arthritis	1.33e-05	4.66e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL6—rheumatoid arthritis	1.32e-05	4.63e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL6—rheumatoid arthritis	1.32e-05	4.62e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TGFB1—rheumatoid arthritis	1.32e-05	4.6e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NOS3—rheumatoid arthritis	1.31e-05	4.58e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PTGS2—rheumatoid arthritis	1.3e-05	4.56e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CXCL8—rheumatoid arthritis	1.3e-05	4.55e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TGFB1—rheumatoid arthritis	1.29e-05	4.53e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL2—rheumatoid arthritis	1.29e-05	4.49e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL6—rheumatoid arthritis	1.28e-05	4.47e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL2—rheumatoid arthritis	1.28e-05	4.47e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL6—rheumatoid arthritis	1.27e-05	4.45e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.27e-05	4.44e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MMP9—rheumatoid arthritis	1.26e-05	4.41e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—VEGFA—rheumatoid arthritis	1.25e-05	4.38e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NFKB1—rheumatoid arthritis	1.25e-05	4.36e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL2—rheumatoid arthritis	1.24e-05	4.35e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL6—rheumatoid arthritis	1.24e-05	4.33e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TGFB1—rheumatoid arthritis	1.24e-05	4.32e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MAPK8—rheumatoid arthritis	1.23e-05	4.29e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MMP9—rheumatoid arthritis	1.22e-05	4.25e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TYK2—rheumatoid arthritis	1.21e-05	4.25e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MMP9—rheumatoid arthritis	1.21e-05	4.23e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.2e-05	4.21e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NFKB1—rheumatoid arthritis	1.2e-05	4.19e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NOS3—rheumatoid arthritis	1.19e-05	4.17e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MAPK8—rheumatoid arthritis	1.18e-05	4.14e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CXCL8—rheumatoid arthritis	1.18e-05	4.13e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MMP9—rheumatoid arthritis	1.18e-05	4.12e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MAPK8—rheumatoid arthritis	1.18e-05	4.12e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.17e-05	4.08e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NFKB1—rheumatoid arthritis	1.16e-05	4.07e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.16e-05	4.06e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TGFB1—rheumatoid arthritis	1.15e-05	4.02e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MAPK8—rheumatoid arthritis	1.14e-05	4e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—VEGFA—rheumatoid arthritis	1.13e-05	3.96e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL2—rheumatoid arthritis	1.13e-05	3.95e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL6—rheumatoid arthritis	1.12e-05	3.93e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL2—rheumatoid arthritis	1.11e-05	3.88e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TP53—rheumatoid arthritis	1.11e-05	3.87e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL6—rheumatoid arthritis	1.1e-05	3.86e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—VEGFA—rheumatoid arthritis	1.09e-05	3.82e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—VEGFA—rheumatoid arthritis	1.09e-05	3.8e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TP53—rheumatoid arthritis	1.08e-05	3.79e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MMP9—rheumatoid arthritis	1.07e-05	3.73e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TP53—rheumatoid arthritis	1.07e-05	3.73e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.06e-05	3.7e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—VEGFA—rheumatoid arthritis	1.06e-05	3.7e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NFKB1—rheumatoid arthritis	1.06e-05	3.7e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MMP9—rheumatoid arthritis	1.05e-05	3.67e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.04e-05	3.64e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MAPK8—rheumatoid arthritis	1.04e-05	3.63e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TGFB1—rheumatoid arthritis	1.04e-05	3.63e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MAPK8—rheumatoid arthritis	1.02e-05	3.57e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TP53—rheumatoid arthritis	1.02e-05	3.56e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL6—rheumatoid arthritis	1.01e-05	3.54e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL2—rheumatoid arthritis	1.01e-05	3.53e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL6—rheumatoid arthritis	1.01e-05	3.51e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TGFB1—rheumatoid arthritis	1e-05	3.51e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TGFB1—rheumatoid arthritis	9.97e-06	3.49e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL6—rheumatoid arthritis	9.92e-06	3.47e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL6—rheumatoid arthritis	9.76e-06	3.41e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TGFB1—rheumatoid arthritis	9.7e-06	3.39e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TP53—rheumatoid arthritis	9.6e-06	3.36e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—VEGFA—rheumatoid arthritis	9.59e-06	3.35e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MMP9—rheumatoid arthritis	9.56e-06	3.34e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TP53—rheumatoid arthritis	9.47e-06	3.31e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	9.46e-06	3.31e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—VEGFA—rheumatoid arthritis	9.44e-06	3.3e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL6—rheumatoid arthritis	9.31e-06	3.26e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	9.3e-06	3.25e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TGFB1—rheumatoid arthritis	8.8e-06	3.08e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6—rheumatoid arthritis	8.78e-06	3.07e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6—rheumatoid arthritis	8.67e-06	3.03e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TGFB1—rheumatoid arthritis	8.66e-06	3.03e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	8.58e-06	3e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TP53—rheumatoid arthritis	8.55e-06	2.99e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TP53—rheumatoid arthritis	8.25e-06	2.89e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TP53—rheumatoid arthritis	8.21e-06	2.87e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TP53—rheumatoid arthritis	7.99e-06	2.79e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	7.88e-06	2.76e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6—rheumatoid arthritis	7.83e-06	2.74e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6—rheumatoid arthritis	7.55e-06	2.64e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6—rheumatoid arthritis	7.51e-06	2.63e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6—rheumatoid arthritis	7.31e-06	2.56e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TP53—rheumatoid arthritis	7.25e-06	2.53e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TP53—rheumatoid arthritis	7.13e-06	2.49e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6—rheumatoid arthritis	6.63e-06	2.32e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6—rheumatoid arthritis	6.53e-06	2.28e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TP53—rheumatoid arthritis	6.49e-06	2.27e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6—rheumatoid arthritis	5.94e-06	2.08e-05	CbGpPWpGaD
